Technology | Radiology Imaging | January 17, 2018

Philips Introduces Technology Maximizer Program for Imaging Equipment Upgrades

Five-year, cross-modality program for structured upgrades maximizes clinical value of Philips imaging system investments, helps manage security risks

Philips Introduces Technology Maximizer Program for Imaging Equipment Upgrades

January 17, 2018 — Philips recently announced the launch of Technology Maximizer, a cross-modality program designed to boost the clinical capabilities and performance of imaging equipment through proactive upgrades. Technology Maximizer provides confidence to radiology and cardiology department leaders and clinicians that their systems are up to date and compliant at a fraction of the cost of individual upgrades, according to Philips.  

Equipment performance is key to increasing efficiency, which is vital for hospitals looking to increase their quality of patient care. When departments are efficient, they become stronger and more productive. Proactive upgrades help keep imaging equipment up to date, which is important for managing security risk. These updates also help keep systems well-maintained, compliant and protected from obsolescence, which helps decrease unexpected downtime. However, complicated financial processes and overburdened staff can often create barriers to obtaining needed and timely system upgrades.

With Philips' Technology Maximizer, healthcare organizations no longer need to upgrade systems or software on an individual basis. Through regular upgrades and by refreshing existing hardware, this five-year subscription program provides radiology and cardiology departments with the latest software and hardware updates while maintaining cost efficiency through a predictable fee. Technology Maximizer is available for selected Philips magnetic resonance (MR), computed tomography (CT), image-guided therapy (IGT) and ultrasound systems, and runs in tandem with existing RightFit Customer Service Agreements.

Philips' Technology Maximizer Pro option provides additional benefits. Organizations that select the Pro option for a clinical domain will automatically receive the latest specialty applications for the domain as Philips releases them. For example, Technology Maximizer Pro is available for MR systems in body, cardiovascular, musculoskeletal and neurology domains.

Technology Maximizer will be commercially available globally, including in North America as well as select markets in Europe, Latin America and Asia Pacific, starting in early 2018.  Technology Maximizer customers will have the latest available software and hardware technology releases for a fraction of the cost of purchasing them individually as an added subscription benefit.

Philips showcased Technology Maximizer at the 2017 Radiological Society of North America (RSNA) Annual Meeting, Nov. 26-Dec. 1 in Chicago.

For more information: www.usa.philips.com/healthcare

 

Related Content

RADLogics AI-Powered solution in use: chest X-ray of COVID-19 positive case with heatmap key image.

RADLogics AI-Powered solution in use: chest X-ray of COVID-19 positive case with heatmap key image.

News | Artificial Intelligence | September 23, 2020
September 23, 2020 — RADLogics
The cartilage in this MRI scan of a knee is colorized to show greater contrast between shades of gray.

The cartilage in this MRI scan of a knee is colorized to show greater contrast between shades of gray. Image courtesy of Kundu et al. (2020) PNAS

News | Artificial Intelligence | September 22, 2020
September 22, 2020 — Researchers at the University of Pitts...
New research from King's College London has found that COVID-19 may be diagnosed on the same emergency scans intended to diagnose stroke.

Canon Medical Systems

News | Cardiac Imaging | September 22, 2020
September 22, 2020 — New research from King's College London has
Philips Azurion Lung Edition supports high precision diagnosis and minimally invasive therapy in one room
News | Lung Imaging | September 21, 2020
September 21, 2020 — Philips introduced...
According to a new report published by P&S Intelligence, the global radiotherapy market is expected to expand from $7.2M in 2019 to $17M by 2030.

Image courtesy of Accuray

Feature | Radiation Therapy | September 21, 2020 | By Melinda Taschetta-Millane
According to a...
According to Philips, MR-STAT is a major shift in MRI, relying on a new, smart acquisition scheme and machine-assisted reconstruction. It delivers multiple quantitative MR parameters in a single fast scan, and represents a significant advance in MR tissue classification, fueling big data algorithms and AI-enabled integrated diagnostic solutions.

Image courtesy of Philips Healthcare

Feature | Magnetic Resonance Imaging (MRI) | September 21, 2020 | By Melinda Taschetta-Millane
A new report,...
Of all the buzzwords one would have guessed would dominate 2020, few expected it to be “virtual”. We have been virtualizing various aspects of our lives for many years, but the circumstances of this one has moved almost all of our lives into the virtual realm.

Getty Images

Feature | Radiology Education | September 18, 2020 | By Jef Williams
Of all the buzzwords one would have guessed would dominate 2020, few expected it to be “virtual”.
Indeterminate lesion on PET/CT classified by PET/MRI for 53-y-old man with lung cancer.

Indeterminate lesion on PET/CT classified by PET/MRI for 53-y-old man with lung cancer. Contrast-enhanced CT (A), PET (B), and fused 18F-FDG PET/CT (C) images are displayed in comparison with contrast-enhanced T1-weighted MRI (D), PET, and fused 18F-FDG PET/MRI (F) images. In CT (A), hyperdense, subcentimeter liver lesion (arrows) in segment VII is suggestive of transient hepatic attenuation difference or small hemangioma. As malignancy cannot be excluded, it needs further investigation. On PET/MRI, lesion is clearly classified as metastasis because of contrast enhancement and tracer uptake due to later acquisition time point. Follow-up CT confirmed diagnosis after 78 d. Images created by Ole Martin, University Dusseldorf, Medical Faculty and Benedikt Schaarschmidt, University Hospital Essen.

News | PET-MRI | September 18, 2020
September 18, 2020 — A single-center observational study of more than 1,000 oncological examinations has demonstrated